Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Stationed in Naples. We got the word and currently spreading the news to families.
-----------
POST #10087 Janice Shell
TRON provided a 15-C regarding a reverse split…
Once again, there is no such thing as a "15-C". The company filed disclosure at OTCMarkets. That's all.
-----------
You are correct, there is no such thing as a 15-C. TRON submitted information that was furnished to assist with "due diligence" compliance. "The information is furnished pursuant to Rule 15c2-11 promulgated by the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended: The items and attachments generally follow the format set forth in Rule 15c2-11." As you said, they filed a disclosure, which is linked in Stickied post #9886.
-----------
POST #10089 Janice Shell
Just because I signed up for cell phone service with AT&T it doesnt mean I am partners with AT&T it means I am an AT&T customer.
Damn! And here I, too, thought I was an AT&T partner.
Jokes aside, this is by no means the first time I've seen a penny company pull this.
-----------
Yes, TRON is a "Pink" company, but you are categorizing TRON with other "Pinks" that have been sub-par, which involves self opinion, not fact. That's not fair for TRON. Instead of instantly assuming TRON is out to scam, why don't us as investor's wait until the end of the 3rd quarter and see what TRON/iMedscan provides. They have provided a disclosure along with a Press Release publicly stating their intentions and plan forward.
-----------
POST #9972 The Rainmaker
The PR was craftily worded, H Wayne knows how to work the system.
Janice Shell's response to Rainmaker's post:
POST #10090 Janice Shell
Sure he does! After all, he got a J.D. from Columbia Law while he was in PRISON!! Clever man!
-----------
This is SOLELY opinion. To say that he craftily worded the PR and to agree with it makes the assumption to investor's that you know H Wayne. I will assume that Neither yourself or Rainmaker knows H Wayne.
Yes, prison. This was 16 years ago correct? Is no human being able to turn over a new leaf? Or are they for-ever flagged as a criminal. He ALSO appealed.
-----------
POST #10091 Janice Shell
So iMed holds proprietary software.
That is what iMedScan says. That cannot be verified.
-----------
This is straight from TRON's Press Release:
"iMedican is a healthcare project development and management company holding a proprietary technology that provides for the instant verification of a patient’s medical insurance."
Yes, sure us as investor's can't just "verify", but stating that "it cannot be verified" is just a blanket statement. To say that it can't be verified is implying that TRON's press Release states fraudulent information. I HIGHLY doubt that, since Change Healthcare and Acuant are also in the Press Release. That would put them in the spot light as well.
-----------
POST #1093 Janice Shell
Just imagine we have gotten 1 Pr so far. I cannot imagine what the next one is going to be like!
I can. It'll be just as vague as the first, but will seem exciting to some.
-----------
Again, the term "vague" is solely on opinion. POST #9982 helps break the "vague" PR, but that was created in how I interpreted it, so I "could" be wrong.
-----------
POST #10096 Janice Shell
No one announces merger plans and agreements publicly with Acuant or a large corporation such as Change Healthcare just to have proprietary technology on "paper and imagination".
lol, would you like me to furnish a list of companies that have done exactly what you suggest? Some got caught; others didn't.
So far, what TRON has said is vague enough that it probably won't get them into trouble.
-----------
TRON's Press Release specifically states TWO things that are not "vague".
"In March, 2016, iMedScan entered into an agreement with Acuant Corporation of Los Angeles, California to employ its proprietary, hosted scanning solution on patient’s driver’s licenses and insurance cards."
AND
"Most recently, in June, 2016, iMedScan finalized a test program with Change America, formerly Emdeon Corpoation, utilizing an electronic data interchange for verifying and validating patients’ health insurance."
That's a clean cut statement involving Acuant Corporation and Change Healthcare.
-----------
POST #10098 Janice Shell
Let's rewind news. Go TRON >>> Proof on paper.
Keep this in mind: TRON is Pink. What it says is "proof" of nothing.
-----------
Yes, TRON is a Pink. They did in fact though put out a Press Release stating their intentions. The "Proof" will be the completion of their merger and subsequent filings. If that's what you need, wait until the end of the 3rd quarter.
-----------
POST #10100 Janice Shell
Have you really never followed a penny stock that lied in its public statements and disclosure? They aren't exactly rare.
-----------
Same as my response to your post #10089. You are assuming EVERY company that starts out "PINK" will lie and scam investor's.
-----------
POST #10101 Janice Shell
IMED has a proprietary technology that allows scanning of licenses and ID cards, quickly verifiying patients information.
How I read it, the agreement is Acuant using iMedscans "scanning technology" for that purpose.
-----------
I cannot argue with your opinion on how you read it.
In my opinion, I read it as iMed allowing Acuant to use iMed's technology. Acuant's technology (with regards to their iScan with ID's) can be used with iMed's proprietary software that scan's ID and medical documents. iMedscan's proprietary technology's purpose is to eliminating claim rejections at healthcare facilities across the Unites States.
-----------
POST #10102 Janice Shell
Take a closer look at Acuant's website. A pity. Earlier, I though you'd got it:
investorshub.advfn.com/boards/read_msg.aspx?message_id=124723177
With penny stocks, it's important not to believe things simply because you want to.
In response to my post:
POST #100101 DJPele
IMED has a proprietary technology that allows scanning of licenses and ID cards, quickly verifiying patients information.
How I read it, the agreement is Acuant using iMedscans "scanning technology" for that purpose.
-----------
Again, it's not a belief simply because i want to believe. The Press Release is there, along with all applicable information. POST's #9982 and #9886 provides related DD to TRON.
In my opinion, I read it as iMed allowing Acuant to use iMed's technology. Acuant's technology (with regards to their iScan with ID's) can be used with iMed's proprietary software that scan's ID and medical documents. iMedscan's proprietary technology's purpose is to eliminating claim rejections at healthcare facilities across the Unites States.
-----------
POST #10104 Janice Shell
I think you need to spend a little more quality time at the Acuant website. Scanning is a large part of what they do.
What I see here is a custodianship shell that will have a hard time getting financing, if whoever they're thinking of going to for that pays any attention at all. And I also see some sleazy characters. And a merger agreement so sloppy it's impossible to tell whether the merger has happened or not.
An agreement, by the way, that makes no mention of any "APO".
-----------
I explained above what my opinion is with regards to Acuant's technology and iMedscan's proprietary technology.
How did you come up with the conclusion that they are having a hard time getting financing. Please explain.
"Seeing some sleezy characters" is based on opinion. As with all opinions, I do not believe this merger is sloppy either.
ASSUMING the Press Release is not fraudulent and holds true, then the PR show's proof of the APO.
"Pursuant to the definitive Agreement and Plan of Merger entered into on March 30, 2016 iMedScan will become public through an alternative public offering or “APO” transaction with Toron."
It's a pity? I'm sorry to dissapoint you Janice. Acuant has ID software for licenses and ID cards. iMed holds proprietary software to scan such ID cards and licenses for the sake of validating Patients Healthcare.
It's in the PR. Simply stating that TRON can't be trusted because the PR is "vauge" and because it's a "pink" are strictly your opinion and shows no truth to the company.
IMED has a proprietary technology that allows scanning of licenses and ID cards, quickly verifiying patients information.
How I read it, the agreement is Acuant using iMedscans "scanning technology" for that purpose.
Thanks!
Correct alyssa. No one announces merger plans and agreements publicly with Acuant or a large corporation such as Change Healthcare just to have proprietary technology on "paper and imagination".
INVESTOR'S: SUPPLEMENTAL DD ON TRON MERGER & APO
The purpose of this is to combine post's #9966, #9886 and #9964. This post is intended to help provide additional supplemental DD to TRON's main Due Diligence MERGER/APO post sticky #9538.
Supplemental DD #1
Please review sticky post #9538. With the help of everyone on this board, it contains a consolidated review, supplemental information and DD on TRON's recent MERGER Press Release and APO with iMed.
TRON is in the process of completing an APO (Alternate Public Offer) which is similar to an IPO, except faster, easier and with private backing.
Links to what an APO is along with examples are contained within sticky post #9538. Other members have also provided details, examples and explanations with their individual post's.
I Highly encourage any new investor's that are interested in TRON to take a look. Also, please review TRON's latest 15-C as well.
http://www.otcmarkets.com/financialReportViewer?symbol=TRON&id=158205
THERE IS a reverse split announced within the 15-C. As investor's on this board explained, IT'S A RECAPITALIZATION OF THE COMPANY'S STOCK FOR THE COMPLETION OF THE APO. I do not recommend reviewing the term "REVERSE SPLIT" as an actual R/S or as a negative. TRON has announced ample information regarding it's merger and the road-map of TRON's future. HOKIEHEAD has made numerous post's explaining how the R/S is in fact a RECAPITALIZATION.
Again, sticky #9538 provides the Press Release and ample supplemental information regarding TRON's merger and APO.
Supplemental DD #2
This takes a closer look into TRON's latest Press Release. Please keep in mind that this is how I interpreted it.
"iMedican is a healthcare project development and management company holding a proprietary technology that provides for the instant verification of a patient’s medical insurance. “iMedcan’s proprietary technology will generate a twenty-five (25%) reduction in patient insurance rejections or denials from insurance payors,” Bostico said."
iMed holds some type of proprietary technology. Information from iMedscan's website (https://imedscan.com) shows that it's potentially a device that scans and verifies ID cards and documents. Here's more:
"In March, 2016, iMedScan entered into an agreement with Acuant Corporation of Los Angeles, California to employ its proprietary, hosted scanning solution on patient’s driver’s licenses and insurance cards."
I am assuming the agreement between Acuant and iMedscan is iMedscan allowing Acuant to utilize iMedscan's proprietary technology, scanning licenses and ID cards.
"Most recently, in June 2016, iMedScan finalized a test program with Change Healthcare, formerly Emdeon Corporation, utilizing an electronic data interchange for verifying and validating patients’ health insurance. “We estimate a fifty (50%) percent net profit recapture from each medical office that adopts our technology,” Bostico noted. Currently, in addition to traditional medical offices, iMedScan is focusing on the further development and commercialization of kiosk devices hosting the company’s scanning solution."
"Kiosk devices hosting the company’s scanning solution." There it is again. iMed and Change Healthcare (formerly Emdeon, which was bought by Black Stone) finalized a test program, estimating a 50% net profit recapture from each medical office that adopts our (iMed's) technology. Change Healthcare will use iMed's technology to verify and validate patients health insurance.
Just an FYI, Change Healthcare is a HUGE corporation.
iMed's reason to create this technology is to eliminate healthcare claim rejections across the United States. Reducing claim rejections decreases company costs.
From conducting some Due Diligence on TRON, it looks as if ACUANT and Change Healthcare will be using iMed's proprietary technology with regards to healthcare.
Fabrizio Bosticco is the CEO of both iMedscan and TRON.
Supplemental DD #3
Here are links SMITTER found regarding Black Stone and Change Healthcare's history.
Black Stone Bought Emdeon for 3 Billion.
http://dealbook.nytimes.com/2011/08/04/blackstone-to-buy-emdeon-for-3-billion/?_r=0
Emedon bought Change Healthcare for 135 Million.
http://www.tennessean.com/story/money/2014/11/19/emdeon-buys-change-healthcare/19306989/
Emdeon to re-brand as Change Healthcare.
http://www.prnewswire.com/news-releases/emdeon-to-rebrand-as-change-healthcare-300137812.html
That depends when their profile was updated. The merger/APO is still a work in progress and not finalized yet.
I re-read the link you provided, and I agree that Acuant has the idScan technology. This is what the iMed site states though:
"The insurance card is scanned via iMedScan, and the scan of the patient’s insurance card is uploaded to a secure web portal for validation."
So, I am assuming that the agreement between them is iMed allowing Acuant to utilize iMedscan's proprietary technology, scanning licenses and medical cards.
You appear to be correct. I'll take another look at the link you provided.
Janice, no.
IT SPECIFICALLY STATES these two paragraphs:
"iMedican is a healthcare project development and management
company holding a proprietary technology that provides
for the instant verification of a patient’s medical insurance.
"In March, 2016, iMedScan entered into an agreement
with Acuant Corporation of Los Angeles, California
to employ its proprietary, hosted scanning
solution on patient’s driver’s licenses and insurance cards."
ACUANT will be using iMedscan's technology, along with Change Healthcare, stated in POST #9966 and #10035.
Why would iMed buy services/technology from Acuant, when iMed holds the proprietary technology.
Then I recommend you review post #9966 which goes into detail, IF the way I interpreted it is correct.
Actually, I'll just post some of it for your leisure Janice.
"iMedican is a healthcare project development and management
company holding a proprietary technology that provides
for the instant verification of a patient’s medical insurance.
Here's more:
"In March, 2016, iMedScan entered into an agreement
with Acuant Corporation of Los Angeles, California
to employ its proprietary, hosted scanning
solution on patient’s driver’s licenses and insurance cards."
So iMed employed it's technology onto licenses and insurance cards, which will help provide instant verification of a patient’s medical insurance.
Lastly:
"Most recently, in June, 2016, iMedScan
finalized a test program with Change America, formerly Emdeon
Corpoation, utilizing an electronic data interchange for verifying
and validating patients’ health insurance. “We estimate a fifty (50%) percent net profit recapture from each medical office that adopts our technology,”
Change Healthcare will use iMed's technology for the sake of verifying and validating patients health insurance. THE WHOLE REASON iMed CREATED THIS TECHNOLOGY is to reduce claim denials and loss of profit, among other things.
That could have been figured out just by checking iMed's website, which the link is below:
https://imedscan.com/
This should help un-vague the PR, and answer some of the questions you've been tirelessly posting.
If what I read and how I interpreted is correct, post #9966 should explain more clearly that we are (iMed) providing the technology.
No reason to. Janice, you can simply read the Press Release, or refer to post #9966.
If I am correct about what I posted, post #9857 should answer your question.
Acuant has signed an agreement with iMedscan to use iMedscan's proprietary technology. Also, they finalized a test program with Change Healthcare using iMedscan's technology, all within TRON's recent Press release. Please refer to post's #9966 and #9538.
Not yet perhaps, but in accordance with the recent press release, iMed entered into an agreement with Acuant, and finalized a test program with Change Healthcare.
TRON's recent press release explains how iMed's technology will be used and what it does with Acuant and Change Healthcare.
Post #9982 put's it out in layman's terms regarding iMed's software.
No problem John, here to help.
From TRON's latest PR:
"iMedican is a healthcare project development and management company holding a proprietary technology that provides for the instant verification of a patient’s medical insurance. “iMedcan’s proprietary technology will generate a twenty-five (25%) reduction in patient insurance rejections or denials from insurance payors,” Bostico said."
So iMed holds proprietary software. Here's more:
"In March, 2016, iMedScan entered into an agreement with Acuant Corporation of Los Angeles, California to employ its proprietary, hosted scanning solution on patient’s driver’s licenses and insurance cards."
iMed entered into an agreement for ACUANT to utilize iMed's proprietary software.
To continue:
"Most recently, in June, 2016, iMedScan finalized a test program with Change America, formerly Emdeon Corpoation, utilizing an electronic data interchange for verifying and validating patients’ health insurance. “We estimate a fifty (50%) percent net profit recapture from each medical office that adopts our technology,” Bostico noted. Currently, in addition to traditional medical offices, iMedScan is focusing on the further development and commercialization of kiosk devices hosting the company’s scanning solution."
iMed and Change America (formerly Emdeon who was bought by Black Stone) both finalized a test program, estimating a 50% net profit recapture from each medical office that adopts our (iMed's) technology.
iMed is also focusing on further development and commercialization of kiosk devices hosting the company’s scanning solution.
From conducting some Due Diligence on TRON, it looks as if ACUANT and Change America will be hosting iMed's proprietary software.
Fabrizio Bosticco, is the CEO of both iMed and TRON.
On top of that, Emdeon re-branded themselves as Change Healthcare.
http://www.prnewswire.com/news-releases/emdeon-to-rebrand-as-change-healthcare-300137812.html
This is very good news.
Good Stuff!
Rain, since you are posting "factual data" you should also post about the recent PR, and the pending Merger and APO, since these are also "factual data".
Roughly 8mil on 7's.
1mil on 8's.
Understood. HAVE YOU read the DD? Are you familiar with the process of what an APO is?
I'm assuming your fairly savvy in regards to small-cap stocks, so it's safe to say that you have experienced a reverse split or two. TRON provided a 15-C regarding a reverse split, followed by a Press Release stating a MERGER and APO to be completed NLT September 30th. So there is a valid reason AND a path TRON is pursuing.
Sticky post #9538 shows a great number of information regarding the merger, it's details AND the Reverse Split.
Rain, this info IS stickied. Please refer to post #9538.
Within that stickied post, I requested investors to review TRON'S 15-C, supplied a link AND copied and pasted that exact paragraph.
There are other posts that explain that it is a recapitalization Of TRON'S STOCK for their pending merger/APO which will be completed 3rd quarter 2016.
Have you read the DD.
It may have been done to try and scare investors
Exactly
Good stuff!
Looking forward to it
"Thin" is an understatement.
.0050 can be seen on the horizon. .0045 is LITERALLY a step away
Possibly.
Bid 10,000 at .0006
Ask 10,000 at .0006
Anyone have $6 to get to .0007?
Both are 10,000
Yes.
Bid .0006
Ask .0006
Company released a PR with all related information. No story board chatter.
New/Current Investors Due Diligence (DD)
Please review sticky post #9538. With the help of everyone on this board, it contains a consolidated review, supplemental information and DD on TRON's recent MERGER Press Release and APO with iMed.
TRON is in the process of completing an APO (Alternate Public Offer) which is similar to an IPO, except faster, easier and with private backing.
Links to what an APO is along with examples are contained within sticky post #9538. Other members have also provided details, examples and explanations with their individual post's.
I Highly encourage any new investor's that are interested in TRON to take a look. Also, please review TRON's latest 15-C as well.
http://www.otcmarkets.com/financialReportViewer?symbol=TRON&id=158205
THERE IS a reverse split announced within the 15-C. As investor's on this board explained, IT'S A RECAPITALIZATION OF THE COMPANY'S STOCK FOR THE COMPLETION OF THE APO. I do not recommend reviewing the term "REVERSE SPLIT" as an actual R/S or as a negative. TRON has announced ample information regarding it's merger and the road-map of TRON's future. HOKIEHEAD has made numerous post's explaining how the R/S is in fact a RECAPITALIZATION.
Again, sticky #9538 explains in detail the Press Release and ample supplemental information regarding TRON's merger and APO.
If any investor has questions, please feel free to ask anyone on this board. I would like this board to be as healthy and helpful as possible.
I will re-post Post #9844 either prior to or right after the market open's. Hopefully investor's will see it before it gets buried with all the other post's.
It explains that the R/S is a recapitalization.